Cervical Cancer Vaccine is Approved in South Africa
A cervical cancer vaccine has been given the go-ahead for use in South Africa, a pharmaceutical company has said. Glaxo SmithKline (GSK) said the vaccine had been approved and registered by the Medicines Control Council. An estimated 6 700 South African women develop cervical cancer every year.